Cargando…
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data
BACKGROUND: Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comorbidities. Therefore, we investigated the effect o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318940/ https://www.ncbi.nlm.nih.gov/pubmed/33704552 http://dx.doi.org/10.1007/s00392-021-01822-1 |
_version_ | 1783730351668985856 |
---|---|
author | Marcks, Nick Aimo, Alberto Januzzi, James L. Vergaro, Giuseppe Clerico, Aldo Latini, Roberto Meessen, Jennifer Anand, Inder S. Cohn, Jay N. Gravning, Jørgen Ueland, Thor Bayes-Genis, Antoni Lupón, Josep de Boer, Rudolf A. Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Tentzeris, Ioannis Ripoli, Andrea Passino, Claudio Sanders-van Wijk, Sandra Emdin, Michele Brunner-La Rocca, Hans-Peter |
author_facet | Marcks, Nick Aimo, Alberto Januzzi, James L. Vergaro, Giuseppe Clerico, Aldo Latini, Roberto Meessen, Jennifer Anand, Inder S. Cohn, Jay N. Gravning, Jørgen Ueland, Thor Bayes-Genis, Antoni Lupón, Josep de Boer, Rudolf A. Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Tentzeris, Ioannis Ripoli, Andrea Passino, Claudio Sanders-van Wijk, Sandra Emdin, Michele Brunner-La Rocca, Hans-Peter |
author_sort | Marcks, Nick |
collection | PubMed |
description | BACKGROUND: Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comorbidities. Therefore, we investigated the effect of BMI on outcome in younger patients without co-morbidities as compared to older patients with co-morbidities in a large heart failure (HF) population. METHODS: In an individual patient data analysis from pooled cohorts, 5,819 patients with chronic HF and data available on BMI, co-morbidities and outcome were analysed. Patients were divided into four groups based on BMI (i.e. ≤ 18.5 kg/m(2), 18.5–25.0 kg/m(2); 25.0–30.0 kg/m(2); 30.0 kg/m(2)). Primary endpoints included all-cause mortality and HF hospitalization-free survival. RESULTS: Mean age was 65 ± 12 years, with a majority of males (78%), ischaemic HF and HF with reduced ejection fraction. Frequency of all-cause mortality or HF hospitalization was significantly worse in the lowest two BMI groups as compared to the other two groups; however, this effect was only seen in patients older than 75 years or having at least one relevant co-morbidity, and not in younger patients with HF only. After including medications and N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin concentrations into the model, the prognostic impact of BMI was largely absent even in the elderly group with co-morbidity. CONCLUSIONS: The present study suggests that obesity is a marker of less advanced disease, but does not have an independent protective effect in patients with chronic HF. GRAPHIC ABSTRACT: Categories of BMI are only predictive of poor outcome in patients aged > 75 years or with at least one co-morbidity (bottom), but not in those aged < 75 years without co-morbidities (top). The prognostic effect largely disappears in multivariable analyses even for the former group. These findings question the protective effect of obesity in chronic heart failure (HF). [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01822-1. |
format | Online Article Text |
id | pubmed-8318940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-83189402021-08-13 Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data Marcks, Nick Aimo, Alberto Januzzi, James L. Vergaro, Giuseppe Clerico, Aldo Latini, Roberto Meessen, Jennifer Anand, Inder S. Cohn, Jay N. Gravning, Jørgen Ueland, Thor Bayes-Genis, Antoni Lupón, Josep de Boer, Rudolf A. Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Tentzeris, Ioannis Ripoli, Andrea Passino, Claudio Sanders-van Wijk, Sandra Emdin, Michele Brunner-La Rocca, Hans-Peter Clin Res Cardiol Original Paper BACKGROUND: Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comorbidities. Therefore, we investigated the effect of BMI on outcome in younger patients without co-morbidities as compared to older patients with co-morbidities in a large heart failure (HF) population. METHODS: In an individual patient data analysis from pooled cohorts, 5,819 patients with chronic HF and data available on BMI, co-morbidities and outcome were analysed. Patients were divided into four groups based on BMI (i.e. ≤ 18.5 kg/m(2), 18.5–25.0 kg/m(2); 25.0–30.0 kg/m(2); 30.0 kg/m(2)). Primary endpoints included all-cause mortality and HF hospitalization-free survival. RESULTS: Mean age was 65 ± 12 years, with a majority of males (78%), ischaemic HF and HF with reduced ejection fraction. Frequency of all-cause mortality or HF hospitalization was significantly worse in the lowest two BMI groups as compared to the other two groups; however, this effect was only seen in patients older than 75 years or having at least one relevant co-morbidity, and not in younger patients with HF only. After including medications and N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin concentrations into the model, the prognostic impact of BMI was largely absent even in the elderly group with co-morbidity. CONCLUSIONS: The present study suggests that obesity is a marker of less advanced disease, but does not have an independent protective effect in patients with chronic HF. GRAPHIC ABSTRACT: Categories of BMI are only predictive of poor outcome in patients aged > 75 years or with at least one co-morbidity (bottom), but not in those aged < 75 years without co-morbidities (top). The prognostic effect largely disappears in multivariable analyses even for the former group. These findings question the protective effect of obesity in chronic heart failure (HF). [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01822-1. Springer Berlin Heidelberg 2021-03-11 2021 /pmc/articles/PMC8318940/ /pubmed/33704552 http://dx.doi.org/10.1007/s00392-021-01822-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Marcks, Nick Aimo, Alberto Januzzi, James L. Vergaro, Giuseppe Clerico, Aldo Latini, Roberto Meessen, Jennifer Anand, Inder S. Cohn, Jay N. Gravning, Jørgen Ueland, Thor Bayes-Genis, Antoni Lupón, Josep de Boer, Rudolf A. Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Tentzeris, Ioannis Ripoli, Andrea Passino, Claudio Sanders-van Wijk, Sandra Emdin, Michele Brunner-La Rocca, Hans-Peter Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data |
title | Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data |
title_full | Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data |
title_fullStr | Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data |
title_full_unstemmed | Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data |
title_short | Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data |
title_sort | re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318940/ https://www.ncbi.nlm.nih.gov/pubmed/33704552 http://dx.doi.org/10.1007/s00392-021-01822-1 |
work_keys_str_mv | AT marcksnick reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT aimoalberto reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT januzzijamesl reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT vergarogiuseppe reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT clericoaldo reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT latiniroberto reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT meessenjennifer reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT anandinders reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT cohnjayn reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT gravningjørgen reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT uelandthor reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT bayesgenisantoni reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT luponjosep reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT deboerrudolfa reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT yoshihisaakiomi reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT takeishiyasuchika reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT egstrupmichael reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT gustafssonida reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT gagginhannak reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT eggerskaim reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT huberkurt reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT tentzerisioannis reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT ripoliandrea reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT passinoclaudio reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT sandersvanwijksandra reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT emdinmichele reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata AT brunnerlaroccahanspeter reappraisaloftheobesityparadoxinheartfailureametaanalysisofindividualdata |